The authors examined agreement between drug treatment data and a discharge diagnosis of diabetes, considered whether agreement was modified by demographic variables and measures of comorbidity, and evaluated construct validity through consideration of relations with subsequent mortality. The study sample comprised 81,700 residents of New Jersey aged 65-99 years who had prescription drug coverage either through Medicaid or that state's Pharmacy Assistance for the Aged and Disabled program and had at least one hospitalization between July 1,1989, and June 30, 1991. In this population, 16.4% filled a prescription for insulin or an oral hypoglycemic agent during the 120 days before admission, and 16.3% had a discharge diagnosis of diabetes. Overall agreement between these two indicators was modest (kappa = 0.67, 95% confidence interval 0.66-0.67) and was weaker in those aged 85 years and above (kappa = 0.58, 95% confidence interval 0.56-0.60), those in nursing homes (kappa = 0.42, 95% confidence interval 0.39-0.44), and those with a high level of comorbidity (modified Charlson index £ 5; kappa = 0.59, 95% confidence interval 0.56-0.62). Presence of a diagnosis of diabetes was associated with an apparent 24% reduction in the risk of death during the study interval (p< 0.001), while prior treatment for diabetes had little relation to mortality (p = 0.15). These paradoxical associations with mortality and the lower agreement between discharge diagnoses and drug treatments associated with older age, nursing home residence, and comorbidity suggest limitations in the use of claims data to identify diabetes in the elderly. Am J Epidemiol 1999;149:541-9.
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aging; diabetes mellitus; drug prescriptions; drug utilization; nursing homes Although consensus is good on clinical criteria for the diagnosis of diabetes at the level of the individual patient, implementation of these criteria in large populations is often impractical. Epidemiologic studies of the prevalence, incidence, and clinical consequences of diabetes mellitus have used differing methods to identify people with diabetes, and these differences can substantially influence their results. Commonly used approaches include reliance on self-report by a patient of treatment or of a diagnosis of diabetes (1, 2) , review of diagnoses from hospital or physician records (3, 4) , review of administrative records for filled pre-scriptions for insulin or oral hypoglycemic drugs (5, 6) , and screening of serum glucose levels, either in the fasting state or after a glucose challenge (7) (8) (9) (10) . A limitation of each of the first three approaches is that 35-51 percent of all people with diabetes in the United States have never been diagnosed (7, 8) . Those with undiagnosed diabetes may differ in important ways from diagnosed diabetics; the prevalence of undiagnosed diabetes increases with age, and obese individuals are more likely to be screened than are those of normal weight (11) . Moreover, the decision to initiate or maintain treatment or to diagnose diabetes can be affected by both demographic factors and comorbid conditions (12) .
Because of the logistic difficulties in conducting serum glucose measurements in large populations, epidemiologic studies of diabetes have often relied on self-reports or medical records to identify people with diagnosed diabetes. Validation studies comparing selfreports or discharge diagnoses of diabetes with medical records have reported excellent agreement and have also confirmed that a high percentage of such diagnoses meet rigorous diagnostic criteria for diabetes (7, (13) (14) (15) (16) (17) . However, studies of self-report have generally been conducted in selected populations, and their results may not be applicable to vulnerable popu-lations, such as the poor, elderly, and cognitively impaired. Computer-assisted review of administrative databases, including hospital diagnoses and filled prescriptions, offers the potential for objective assessment of clinical diabetes in the entire population covered. However, little is known about the extent to which such diagnoses from alternative sources agree and the factors that modify agreement. In particular, some results have suggested that patients with the poorest prognoses may be less likely to have diabetes coded on their discharge summaries (18) , perhaps because space is available for only a limited number of discharge diagnoses or because only the most severe conditions are coded.
In this paper, we examine the agreement between drug treatment and a discharge diagnosis of diabetes in a large elderly population. Perfect agreement between these two approaches to identify people with diabetes is not expected because about 12 percent of those who report diabetes also relate that they are not currently treated (19) . However, both approaches have been commonly used in epidemiologic studies to identify people with diabetes. We also evaluate whether demographic variables and measures of comorbidity modify agreement. Finally, we assess construct validity by consideration of the relation of treatment and diagnosis of diabetes with subsequent mortality.
MATERIALS AND METHODS

Population
The population for this study consisted of all residents of New Jersey who, according to Medicare records, were hospitalized at least once between July 1, 1989, and June 30, 1991, were aged 65-99 years at the time of hospitalization, and satisfied minimal requirements for participation (defined below) in either the New Jersey Medicaid program or that state's Pharmacy Assistance for the Aged and Disabled program. We determined participation in these programs through review of pharmacy claims files, which contain information on all prescriptions filled by enrollees, including the National Drug Code and the date dispensed. All study participants were required to have filled at least one prescription in either program during the 6 months prior to hospitalization. For participants with more than one hospitalization during the study period, one hospital stay was selected at random for this study.
Each year between 1989 and 1991, an average of 71,599 enrollees in the New Jersey Medicaid program who were aged 65-99 years filled at least one prescription. Whereas nationwide 7 percent of individuals aged 65 years or older were covered by Medicaid, in New Jersey this was 9 percent, attesting to the slightly more lenient eligibility requirements in this state. The New Jersey Medicaid program has no deductible, no maximum benefit, and charges no copayment for prescription drugs, ensuring complete ascertainment of drug use.
Each year between 1989 and 1991, an average of 177,121 enrollees aged 65-99 years in New Jersey's Pharmacy Assistance for the Aged and Disabled program filled at least one prescription. This program has no deductible and no maximum benefit, but there is a nominal $2 copayment for each prescription. Since income-eligibility criteria are more generous than are those of Medicaid, the Pharmacy Assistance for the Aged and Disabled program includes the nonpoor. During the study period, eligibility required an annual income below $15,700 if single and $19,250 if married. This is the highest income ceiling of any such program nationally, producing a recipient population that is both large and further from extreme poverty.
During the 2-year study period, 81,700 individuals met study eligibility requirements: 56,833 filled a prescription only within the Pharmacy Assistance for the Aged and Disabled program, 23,601 filled a prescription only within the Medicaid program, and 1,266 filled prescriptions within both programs in the 6 months prior to their hospitalization. While eligible individuals who filled no prescriptions during this period would be missed, this number is likely to be small for several reasons. About 70-75 percent of the elderly take one or more prescription medications during any 2-week period (20) , entitlement programs such as Medicaid and the Pharmacy Assistance for the Aged and Disabled program commonly enroll moreimpaired individuals with greater need for prescription drugs, and enrollees have a strong financial incentive to use these programs when filling prescriptions.
Measures
Patients were classified as having diabetes according to Medicare records if either primary or any secondary diagnosis upon hospital discharge indicated diabetes (International Classification of Diseases, Ninth Revision (21), code 250 with any suffix). Within the Medicaid or Pharmacy Assistance for the Aged and Disabled program, treatment for diabetes was indicated through a filled claim for insulin or any oral hypoglycemic drug, as indicated by National Drug Code data on filled prescription claims. While some patients may not have complied in taking these medications, such evidence of filled prescriptions is commonly used to indicate drug treatments (22) . We classified patients as being treated for diabetes according to drug claims if they filled such a prescription within the 120 days prior to their hospitalization.
We evaluated seven potential modifiers of agreement between a diagnosis and treatment of diabetes. Age, sex, and race were obtained from Medicare eligibility files. We used both Medicare and Medicaid claims files to identify those patients who were in a nursing home at any time during the 120 days prior to hospital admission. As a measure of overall drug utilization, we counted the number of different classes of drugs according to the American Hospital Formulary System (23) (exclusive of hypoglycemic agents) for which an individual filled prescriptions during the 120 days before hospitalization. To quantify the severity of comorbidity during the hospitalization, we used the Charlson comorbidity index (24) , calculated as recommended by Deyo et al. (25) , but modified by exclusion of the contributions of diabetes to this index. Finally, we also classified patients according to their participation in the two prescription programs (i.e., filled prescriptions in Medicaid only, in the Pharmacy Assistance for the Aged and Disabled program only, or in both programs in the 6 months prior to admission).
Analysis
In initial analyses, we calculated the prevalence of drug treatment and a discharge diagnosis of diabetes, both overall and within categories of the seven potential determinants described above. We did not assume that one measure of diabetes was more valid than another. We used the kappa statistic to quantify agreement between treatment and diagnosis of diabetes adjusted for chance agreement and calculated this statistic both in the entire population and within categories of potential determinants. Estimation of overall and stratum-specific kappa values and their 95 percent confidence intervals used the approach described by Fleiss et al. (26) .
To examine multivariate relations of agreement between hypoglycemic treatment and a diagnosis of diabetes, we fitted logistic regression models within two separate subgroups. First, we restricted attention to the 13,289 individuals who were treated for diabetes in the 120 days before hospitalization and examined determinants of whether they also had a discharge diagnosis of diabetes. We then restricted analysis to the 13,361 individuals with a discharge diagnosis of diabetes and examined whether they filled prescriptions for hypoglycemic drugs in the 120 days before their hospitalization. In a further subgroup analysis, we restricted attention to the 3,152 individuals with a primary discharge diagnosis of diabetes because such a primary diagnosis may be a more reliable indicator of diabetes (15) . We fitted logistic regression models to control for potential confounding among the determinants in estimation of the odds of treatment or diagnosis of diabetes. To evaluate the goodness-of-fit of these models, we used the Hosmer-Lemeshow statistic and considered the area under the receiver operating characteristic curve (27) .
To evaluate the construct validity of prior drug treatment and a diagnosis of diabetes, we examined the ability of these markers to predict mortality at or after discharge using a proportional hazards model. Available evidence indicates that the increased risk of death associated with diabetes remains strong in the elderly (28) (29) (30) . Because relations might differ between mortality up to 30 days after discharge and thereafter (i.e., the assumption of proportional hazards might not hold throughout the follow-up period), we fitted separate proportional hazards models in these two intervals.
RESULTS
Overall, 16.4 percent of the 81,700 hospitalized elderly enrollees in Medicaid or the Pharmacy Assistance for the Aged and Disabled Program filled at least one prescription for a hypoglycemic agent in the 120 days prior to their hospitalization, and 16.3 percent had a discharge diagnosis of diabetes (table 1) . However, agreement between these two measures of diabetes was far from perfect (kappa = 0.67); 11.8 percent of the population had both drug treatment and a discharge diagnosis for diabetes, 4.6 percent of the population had only drug treatment, and 4.5 percent had only a discharge diagnosis. The prevalences of both measures of diabetes declined substantially with increasing age and were also substantially lower among those who were in a nursing home in the 120 days prior to admission. Patients who filled prescriptions for more classes of drugs (exclusive of hypoglycemic agents) had higher prevalences of diabetes by both measures. Patients with intermediate scores on the modified Charlson index had higher prevalences of diabetes relative to those with the lowest and highest scores.
Agreement between diagnosis and treatment varied substantially across categories of demographic variables and measures of comorbidity (table 1, last two columns). Weaker agreement (kappa < 0.60) was observed in the oldest individuals, in nursing home residents, in patients who used both the Medicaid and the Pharmacy Assistance for the Aged and Disabled programs, and among those with the lowest and highest modified Charlson indexes. The strongest agreement (kappa = 0.70) was found for patients aged 65-74 years and among those who were not in nursing homes.
Among the 13,361 patients who filled a prescription for a hypoglycemic agent in the 120 days before their hospitalization, 71.9 percent {n = 9,608) also had a discharge diagnosis of diabetes (table 2) . However, in this subgroup, the odds of a discharge diagnosis of diabetes varied substantially by age, sex, race, nursing home residence, number of claims for different drugs, and comorbidity. In multivariate analysis, older age, nursing home residence, and increasing number of claims for different drugs each predicted reduced odds of a discharge diagnosis of diabetes. Conversely, female sex and black race each predicted an increased odds of a discharge diagnosis of diabetes. The modified Charlson index had a nonlinear relation to a discharge diagnosis of diabetes: The odds increased for scores of 1 to 4 relative to 0 and then decreased substantially for scores above 5. Of the 13,289 patients who had a discharge diagnosis of diabetes, 72.3 percent (n = 9,608) filled a prescription for a hypoglycemic agent in the 120 days before hospitalization (table 3) . In this subgroup, the prevalence of drug treatment for diabetes varied by age, nursing home residence, prescription program, and number of claims for different drugs. In multivariate analysis, older patients and those in nursing homes had lower odds of treatment for diabetes. Those enrolled in the Pharmacy Assistance for the Aged and Disabled program, relative to those enrolled only in Medicaid, and those who filled prescriptions in more different classes of drugs had higher odds of drug treatment for diabetes.
Among the 3,152 individuals with diabetes as the primary discharge diagnosis, 75.4 percent (n = 2,378) filled a prescription for a hypoglycemic agent in the 120 days before hospitalization. A logistic regression model fitted to data from these 3,152 individuals also found that older patients and those in nursing homes had highly significant lower odds of treatment for diabetes comparable with the effects shown in table 3 (data not shown).
As a measure of construct validity, we evaluated the relations of prior treatment or diagnosis of diabetes with subsequent death (figure 1). When we adjusted for demographic variables and measures of comorbidity, those with a discharge diagnosis of diabetes had a highly significant 24 percent reduction in overall death rate at or after discharge. This reduction was greater in the first 30 days after discharge (31 percent), compared with after 30 days (14 percent) but it remained significant in this latter period (p < 0.001). Drug treatment for diabetes before admission had little association with overall mortality (risk reduction of 3 percent, p = 0.15), although subjects treated for diabetes had a 5 percent lower death rate (p = 0.024) in the first 30 days after discharge.
DISCUSSION
Neither use of a hypoglycemic medication nor a discharge diagnosis of diabetes constitutes a definitive approach to identify people with diabetes in a population. Both approaches will miss the estimated 35-51 percent of diabetics who are undiagnosed, although one might expect that hospitalization would enhance detection. Previous studies have suggested that each of these approaches performs well overall in identifying elderly people with diagnosed diabetes. In particular, studies comparing claims reports of diabetes with reabstracted medical records (14) or clinical databases (15) find a sensitivity of 0.83-0.84 and a specificity of 0.98. However, these studies were based on independent assessments of the same hospitalization rather than on the independent patient encounters used for the different sources in our study, and, hence, they did not include an important source of variability. We found that discharge diagnoses had a sensitivity of 0.72 to identify people with treated diabetes, and treatment records also had a sensitivity of 0.72 to identify people with a discharge diagnosis of diabetes. Moreover, those who are missed by either of these approaches are not a random sample of people with diabetes; such factors as age, race, nursing home residence, and comorbidity clearly affect the likelihood of treatment or of the recording of a diagnosis of diabetes.
Our logistic regression analyses indicate that weaker agreement between use of a hypoglycemic drug and a discharge diagnosis of diabetes associated with older age and nursing home residence arises for two reasons. First, both older age and nursing home residence independently predict the probability that a hospitalized individual who is treated for diabetes will not have diabetes coded upon discharge. This may occur because many other conditions or more serious diseases are present in these individuals. However, the substantial independent effects of age and nursing home residence remained after control for available measures of comorbidity. Second, older individuals and those residing in nursing homes who had discharge diagnoses of diabetes were less likely to have been receiving drug treatment for their diabetes. Perhaps physicians hesitate to treat pharmacologically the oldest and sickest diabetics due to concern about side effects of hypoglycemic drugs (31) and about the lack of evidence from randomized trials demonstrating the efficacy of these drugs in the very old.
One might expect and Melton et al. (32) have previously found that people with diabetes identified through hospital or treatment records have moresevere diabetes and more complications than those with diabetes who are not identified by these sources during a 1-year period. However, Iezzoni et al. (18) previously reported that, among hospitalized individ- Relative risk of death associated with a diagnosis or treatment of diabetes among 81,700 elderly residents of New Jersey, 1989-1991, adjusted for age, sex, race, nursing home residence, reimbursement program, number of different drugs, and the modified Charison index. Dx, incidence rate ratio and 95% confidence interval comparing those with a diagnosis of diabetes with those without this diagnosis; Rx, incidence rate ratio and 95% confidence interval comparing those using hypoglycemic drugs with those not using these drugs.
uals, a diagnosis of adult-onset diabetes was associated with a decreased risk of in-hospital death. They concluded that bias against coding of chronic comorbid conditions on the discharge abstracts of patients who die explains this anomalous finding. Our results extend these findings by showing that diabetes is also less likely to be coded on the discharge abstracts of patients who will die even more than 30 days after discharge and that this result remains highly significant even with control for demographic variables and measures of comorbidity. This result is consistent with our other evidence that diabetes is less likely to be identified in those who are particularly old, who have high levels of comorbidity, or who reside in a nursing home. Apparently, the ability to identify people with diabetes through discharge diagnoses from Medicare claims data is limited. In addition to age, nursing home residence, and comorbidity, we also found that race and insurance plan affected some measures of agreement between drug treatment and a discharge diagnosis of diabetes. For example, blacks treated for diabetes had a 51 percent higher odds of having a discharge diagnosis of diabetes compared with treated whites. This elevation may occur because blacks have higher rates of complications from diabetes than do whites. In support of this hypothesis, we found that while blacks constituted 18.8 percent of those with a discharge diagnosis of diabetes, 23.8 percent of those with a primary discharge diagnosis of diabetes were black. However, other reasons might explain this result and include the possibility that blacks with mild diabetes are less likely to be treated than are whites. We have previously reported, based on data from this population, that treatment rates for glaucoma in blacks are less than expected, given their relative burden of disease (33) .
The observed lower odds of drug treatment for diabetes among Medicaid patients with a discharge diagnosis of diabetes compared with enrollees in the Pharmacy Assistance for the Aged and Disabled program has several possible explanations. While it is possible that Medicaid enrollees are undertreated for diabetes relative to enrollees in the Pharmacy Assistance for the Aged and Disabled program, residual confounding by markers of frailty or comorbidity that are unmeasured in this data set is a more likely explanation. Medicaid enrollees are far more likely to be aged 85 years or older, to reside in a nursing home, and to have multiple comorbidities compared with those in the Pharmacy Assistance for the Aged and Disabled program. Differential ascertainment of drugs is unlikely to explain this difference in use of hypoglycemic agents between patients in different reimbursement programs because Medicaid enrollees are poorer and, hence, have a greater incentive to fill prescriptions through this program.
We did not assume that either drug treatment or a discharge diagnosis constituted a more valid measure of diabetes. For hospitalized populations, we believe that each measure has its strengths because discharge diagnoses, although limited in number, can identify those with diet-treated or newly diagnosed diabetes. However, if the goal were to identify all people with diabetes enrolled in Medicaid or the Pharmacy Assistance for the Aged and Disabled program, then use of drug treatment records would be much better. In any given year, only about 20 percent of those aged 65 years or older are hospitalized (34) . Hence, reliance on hospital records is an unacceptable approach to identify people with diabetes in the general population. However, if the goal is to conduct a case-control or cohort study among hospitalized patients, both hospital and drug treatment records are valuable sources to identify diseases, including diabetes.
A variety of statistical approaches are available for the multivariate analysis of agreement between two indicators of disease, such as drug treatment and a discharge diagnosis of diabetes (35) (36) (37) . One straightforward approach uses a logistic regression analysis with a dichotomous outcome variable defined as one if both measures agree and zero if they disagree (37) . An advantage of this approach is that it utilizes data from the entire population. However, a disadvantage is that it groups together two types of disagreement (i.e., drug treatment without a discharge diagnosis and a discharge diagnosis without drug treatment). Our separate analyses of these two types of disagreement find that some variables have different relations with these two types of disagreement. Specifically, the number of claims for different drugs had a strong positive relation with drug treatment for diabetes among those with a discharge diagnosis of diabetes, whereas this variable had a negative association with a discharge diagnosis of diabetes among those taking hypoglycemic drugs. Similarly, the modified Charlson index had different relations with the two types of disagreement. Conversely, older age and nursing home residence had strong positive relations with both types of disagreement, suggesting that these variables were associated with reduced rates of both treatment and diagnosis.
The major limitation of our study is that we had no independent, objective measures of glucose tolerance in study participants, a common problem in largescale, population-based studies. Some of the discrepancies between drug treatments and discharge diagnoses of diabetes may have arisen from differences in the alternative methods of case identification. The initial diagnosis for some diabetics may have occurred in the hospital, and thus, they would have had no previous treatment. However, it is unclear why such initial diagnoses would occur far more commonly among older patients and those in nursing homes, particularly since patients in nursing homes are ostensibly under constant clinical surveillance. Similarly, some diabetics are treated by diet alone, and a systematic tendency to prefer diet treatment for older or sicker patients because of the side effects of drugs may have contributed to our findings.
These results suggest that identification of diabetes through either prescription claims or discharge diagnoses alone has limited validity. Commonly, both casecontrol and cohort studies are conducted by using demographic measures and markers of disease taken from claims data. Examples include studies of adverse effects associated with use of specific medications (6) and studies of prognosis after hospital discharge in cohorts of patients (38) . Follow-up of cohorts whose diabetes is identified through claims data may underestimate the risks associated with diabetes in the elderly because the oldest and sickest diabetics are differentially excluded. Use of claims data to adjust for comorbidity due to diabetes is similarly problematic. Of particular concern are studies including large numbers of very old patients, those with substantial comorbidity, or those residing in nursing homes.
It is likely that use of multiple sources to identify people with diabetes will improve the ability to detect diabetics. However, studies are needed to determine whether those individuals identified as diabetics through only one source truly have the disease. When multiple sources are used, statistical approaches such as capture-recapture techniques can give improved estimates of prevalence. However, these methods commonly assume that the "catchability" of individuals in the population is uniform (39) . If, as suggested by our data, diabetes is less likely to be detected in older and sicker individuals, then even use of multiple sources to identify diabetics can lead to inaccurate description of the patterns and consequences of this disease.
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